The proband’s younger sister (II-2, aged 40) had insulin-treated gestational diabetes when aged 31 and was diagnosed to have T2D at the age of 38 during screening (FPG 170 mg/dL, A1C 7.7%). This evidence concerns the gene INS and type 2 diabetes mellitus.